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Inadequate adenosine-to-inosine editing of noncod-
ing regions occurs in disease but is often uncorre-
lated with ADAR levels, underscoring the need
to study deaminase-independent control of editing.
C. elegans have two ADAR proteins, ADR-2 and
the theoretically catalytically inactive ADR-1. Using
high-throughput RNA sequencing of wild-type and
adr mutant worms, we expand the repertoire of
C. elegans edited transcripts over 5-fold and confirm
that ADR-2 is the only active deaminase in vivo.
Despite lacking deaminase function, ADR-1 affects
editing of over 60 adenosines within the 30 UTRs of
16 different mRNAs. Furthermore, ADR-1 interacts
directly with ADR-2 substrates, even in the absence
of ADR-2, and mutations within its double-stranded
RNA (dsRNA) binding domains abolish both binding
and editing regulation. We conclude that ADR-1
acts as a major regulator of editing by binding ADR-
2 substrates in vivo. These results raise the possibil-
ity that other dsRNA binding proteins, including the
inactive human ADARs, regulate RNAediting through
deaminase-independent mechanisms.
INTRODUCTION
RNA editing is a posttranscriptional process that introduces
changes in RNA sequences and structures (Gott and Emeson,
2000). The most prevalent form of RNA editing in metazoa
is the hydrolytic deamination of adenosine (A) to inosine (I)
(Nishikura, 2010). Adenosine deaminases that act on RNAC(ADARs) bind to double-stranded regions of RNA and catalyze
this type of editing (Goodman et al., 2012; Savva et al., 2012).
Although RNA editing was initially thought to be restricted to a
few select mRNAs in the central nervous system, it is now clear
that adenosine deamination is widespread, with current esti-
mates of 400,000–1,000,000 A-to-I edits in the human transcrip-
tome (Ramaswami et al., 2013).
Adenosine and inosine have different base-pairing properties;
therefore, editing alters RNA structure. Furthermore, given that
inosine is recognized as guanosine by cellular machinery, RNA
editing can modify splice sites, alter the amino acid encoded
by a codon, and redirect microRNAs (miRNAs) and small inter-
fering RNAs (siRNAs) to new targets (Hundley and Bass, 2010;
Rosenthal and Seeburg, 2012). Given that the extent of RNA
editing varies during development and between cell types
(Wahlstedt et al., 2009), this type of modification dynamically
regulates gene expression (Tan et al., 2009).
The molecular diversity generated by ADARs is most pro-
nounced in the brain transcriptome (Blow et al., 2004; Paul and
Bass, 1998). Consistent with this, deletion of ADARs in lower
organisms, such as C. elegans and Drosophila, results in
behavioral defects (Palladino et al., 2000; Tonkin et al., 2002),
indicating that RNA editing is required for proper neuronal func-
tion. Furthermore, alterations in editing levels have been
observed in a number of neuropathological diseases, including
epilepsy, depression, amyotrophic lateral sclerosis, and brain
tumors (Farajollahi and Maas, 2010; Tariq and Jantsch, 2012).
In both development and disease, ADAR expression levels do
not directly correlate with the extent of editing (Maas et al., 2001;
Wahlstedt et al., 2009), implying that other mechanisms exist to
regulate ADAR-mediated RNA editing. Both alternative splicing
(Lai et al., 1997; Rueter et al., 1999) and posttranslational
modification (Desterro et al., 2005) of ADARs generate less
active variants of ADARs. Likewise, editing can be inhibited byell Reports 6, 599–607, February 27, 2014 ª2014 The Authors 599
sequestration of ADAR in the nucleolus (Sansam et al., 2003) or
enhanced by proteins that promote nuclear localization of
ADARs (Marcucci et al., 2011; Ohta et al., 2008). In addition to
proteins that directly regulate ADARs, it has recently been
demonstrated that both the local RNA structure (Daniel et al.,
2012) and RNA binding protein (RBP) landscape of individual
transcripts (Tariq et al., 2013) regulate ADAR activity. To date,
none of these mechanisms have been linked to reduced RNA
editing activity in disease (Orlandi et al., 2012). Furthermore, it
is unlikely that regulators of specific transcripts will play a key
role in the global hypoediting of transcripts observed in many
human cancers and neurological diseases.
To identify mechanisms that could decrease global RNA edit-
ing levels, we focused on the role of catalytically inactive ADAR
family members. The C. elegans genome encodes two proteins
with the common ADAR family domain structure (ADR-1 and
ADR-2). However, ADR-1 lacks several key amino acids required
for deaminase activity. Worms lacking the adr-2 gene have no
detectable editing of the six known edited endogenous mRNAs
(Tonkin et al., 2002), suggesting that ADR-2 is the catalytically
active ADAR protein in worms. However, initial studies of worms
lacking adr-1 revealed alterations in the editing efficiency of all
six endogenous mRNAs examined (Tonkin et al., 2002). In addi-
tion, recent deep sequencing ofC. elegans small RNAs identified
over 30 small RNAs that are edited in vivo, and each have altered
editing levels in worms lacking adr-1 (Warf et al., 2012). These
prior observations suggest ADR-1 regulates editing. However,
it is also possible that background mutations in the strains lack-
ing adr-1 contribute to alterations in editing or that loss of adr-1
indirectly affects editing by ADR-2. To directly address these
concerns, we developed a quantitative assay to measure in vivo
editing levels of worms expressing adr-1 transgenes. About 40%
of adenosines within three known edited mRNAs were affected
by loss of adr-1. Furthermore, using a combination of high-
throughput RNA sequencing of transgenic worms and probabi-
listic modeling we were able to identify 48 edited transcripts
and demonstrate that loss of adr-1 affects editing of at least
half of these newly identified ADAR targets. Using an RNA immu-
noprecipitation (RIP) assay, we demonstrate that ADR-1 directly
binds to known editing targets in vivo, that disrupting this binding
alters editing of the mRNAs, and that ADR-1 and ADR-2 co-
occupy transcripts in vivo. In summary, we demonstrate that
catalytically inactive ADR-1 acts as a global regulator of editing
by binding to target mRNAs and modulating the accessibility of
ADR-2 for target adenosines.
RESULTS
ADR-1 Significantly Alters RNA Editing of Multiple
C. elegans mRNAs
To determine the ability of ADR-1 to directly regulate RNA editing
in vivo,weestablishedaquantitativeassay tomeasurechanges in
editing in worms lacking adr-1 and then tested if these changes
were rescued by an ADR-1 transgene. First, we examined editing
levels at 50 individual adenosines within three known edited
mRNAs: C35E7.6, lam-2, and pop-1. These three mRNAs were
chosen based on their diverse cellular functions and length of
the double-stranded 30 UTR, which range from 517 to 1,423600 Cell Reports 6, 599–607, February 27, 2014 ª2014 The Authorsnucleotides (nts). RNA was isolated from three independent bio-
logical replicates of wild-type and adr-1() adult worms. After
reverse transcription, PCRamplification, andSanger sequencing,
editing efficiency was quantitatively measured using the Bio-Edit
program. Technical replicates of the editing assay suggest
that editing at each site can be determined with <1% error
(Figure S1A), which is consistent with published data on the
accuracy of measuring editing efficiency by Sanger sequencing
(Eggingtonet al., 2011).Of the50editedadenosines,weobserved
statistically significant differences in editing levels between wild-
type and adr-1() worms at 22 individual sites (Figure 1A). The
bulk of the statistically significant sites (91%) had decreased
editing, ranging from 3%–35%, in the absence of adr-1.
To demonstrate that these sites are directly regulated by ADR-
1, a 33 FLAG-tagged genomic version of adr-1 was reintro-
duced to adr-1() worms by microinjection. Importantly, this
transgenic worm rescues a known adr-1 dependent effect on
neuronal protein expression (Hundley et al., 2008), indicating
that the transgene expresses functional ADR-1 protein (Fig-
ure S1B). As the transgenic worms express FLAG-ADR-1 from
an extrachromosomal array that is transmitted to progeny at a
high frequency, but not 100%, a neuronal GFP marker was coin-
jected and flow cytometry was used to purify worms containing
the ADR-1 transgene. In addition, to reduce effects of develop-
mental timing on editing efficiency all worms were also sorted
by size to obtain young adults. The quantitative editing assay
showed that FLAG-ADR-1 significantly restored editing to 15 of
the 22 editing sites altered in adr-1() worms (Figure 1B). It is
important to note that editing changes in the FLAG-ADR-1
worms are not a general phenomenon, because editing sites
that are not affected by loss of adr-1 are not altered by the trans-
gene (Figure S1C). The 15 ADR-1-regulated sites include both
adenosines that have increased and decreased editing in the
absence of adr-1. Together, these data indicate that ADR-1
alters editing of multiple transcripts, but the effects vary depend-
ing upon the individual adenosines examined.
ADR-1 Binds Directly to ADR-2 Target mRNAs In Vivo
Because the effects of adr-1 on editing are site specific, we
hypothesized that ADR-1 is capable of regulating editing by
utilizing two double-stranded RNA binding domains (dsRBDs)
to bind to potential editing substrates and alter accessibility
of ADR-2 to particular nucleotides. To determine if ADR-1 could
bind ADR-2 editing targets in vivo, we developed an RNA immu-
noprecipitation (RIP) assay for ADR-1. Because a previously
generated polyclonal antibody to ADR-1 was incapable of
immunoprecipitating ADR-1 efficiently, the 33 FLAG-tagged
ADR-1 transgenic worm was utilized. To measure specific
binding of ADR-1 to target mRNAs in vivo, we compared immu-
noprecipitates (IPs) from FLAG-ADR-1 and adr-1() worms that
were subjected to UV irradiation (Figure 2A). The IP samples
were treated with Proteinase K to degrade FLAG-ADR-1 and
release ADR-1-associated RNAs into the supernatant. RNA
was extracted from the supernatant, reverse transcribed, and
quantified using real-time PCR. Primers that amplify the three
mRNAs tested in Figure 1 produced 3- to 15-fold more cDNA
in the FLAG-ADR-1 IPs compared to adr-1() IPs (Figure 2B).
In contrast, an mRNA that lacks double-stranded RNA (dsRNA),
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Figure 1. ADR-1 Alters Editing at Specific Adenosines in Multiple mRNAs
(A and B) Editing levels at individual nucleotides within the 30 UTRs were measured for three biological replicates. Error bars represent SEM. Significant changes
(p% 0.05) in editing levels between (A) wild-type and adr-1() or (B) adr-1() and FLAG-ADR-1 are marked with an asterisk.gpd-3, is not enriched, indicating that, in vivo, ADR-1 specifically
binds to these double-stranded ADR-2 target mRNAs.
Because these three mRNAs have both adenosines that are
inhibited and enhanced by ADR-1, these data support the
hypothesis that ADR-1 modulates editing via a direct interaction
with dsRNA. However, in order to regulate editing, ADR-1 needs
to bind to the dsRNA before it is edited. To test this possibility,
we performed the RIP assay in cells expressing FLAG-ADR-1,
but lacking adr-2 and RNA editing. FLAG-ADR-1 was expressed
and immunoprecipitated to a similar level in the presence and
absence of adr-2 (Figure 2C). Compared to the adr-1() worms,
all three ADAR target mRNAs were enriched to a similar extent
in the FLAG-ADR-1 IPs in the presence and absence of adr-2
(Figure 2D), indicating that binding of ADR-1 to known edited
mRNAs is independent of ADR-2. Furthermore, because these
mRNAs have no detectable editing in adr-2() worms, we
conclude that ADR-1 binds unedited mRNAs in the cell.
ADR-1 Alters RNA Editing via Binding to dsRNA In Vivo
Our results indicate that ADR-1 binds to mRNAs that are targets
for editing by ADR-2 in vivo. To determine if this binding isCrequired for the ability of ADR-1 to alter editing in vivo,we created
mutations in the dsRBDs of ADR-1 and examined the effects on
endogenous RNA editing. A patch of lysine (K) residues, referred
to as the KKxxKmotif (x = any amino acid), is required for dsRNA
binding proteins to bind dsRNA (Ramos et al., 2000; Ryter and
Schultz, 1998). Mutation of the lysines to glutamate (E) and
alanine (A) disrupts binding of human ADARs to dsRNA (Valente
and Nishikura, 2007). To disrupt ADR-1 dsRNA binding, the
KKxxKmotif wasmutated to EAxxAwithin both dsRBDs (referred
to as the ds1+2 mutant) (Figure 3A). Similar to the aforemen-
tioned wild-type ADR-1, the ds1+2mutant was 33 FLAG tagged
and reintroduced in the adr-1() background. The FLAG-ADR-1
ds1+2 mutant protein is expressed in the transgenic worms to
about the same level as transgenic wild-type FLAG-ADR-1 (Fig-
ure 3B). To test whether these mutations disrupt ADR-1 binding
to dsRNA, the RIP assay was performed with the ds1+2 mutant.
In contrast to wild-type ADR-1, the ds1+2 mutant IPs were not
enriched for the ADR-2 editing targets (Figure 3C). Thus, the
ds1+2 mutant has defects in mRNA binding in vivo.
To determine if ADR-1 binding to target mRNAs influences
editing efficiency, we compared in vivo editing levels of theell Reports 6, 599–607, February 27, 2014 ª2014 The Authors 601
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Figure 2. ADR-1 Binds ADR-2 Substrates
In Vivo
(A) Lysates from the indicated worm lines were
subjected to FLAG IP and treatment with Protein-
ase K (Prot. K). A portion of the untreated lysate
(IP-, Prot. K), IP (IP+, Prot. K), and beads after
Prot. K treatment (IP+, Prot. K) were subjected to
immunoblotting for the FLAG epitope.
(B) cDNA levels for the indicated endogenous
mRNAs were measured using quantitative real-
time PCR. Values from the IP samples of FLAG-
ADR-1 in adr-1() and the negative control
adr-1() were divided by their respective input
levels. Error bars represent SEM for three bio-
logical replicates.
(C) Lysates from the indicated worm lines were
subjected to immunoprecipitation with magnetic
FLAG resin. A portion of the input lysate and IPs
were subjected to immunoblotting for the FLAG
epitope.
(D) cDNA levels for the indicated endogenous
mRNAs were measured using quantitative real-
time PCR. Ratios of the cDNAs present in the IP
samples of the indicated strains were divided by
their respective input levels and normalized to the
negative control adr-1() to give a fold enrichment.
Error bars represent SEM for three biological
replicates.FLAG-ADR-1 worms to the FLAG-ADR-1 ds1+2 mutant at the
15 sites that were identified as significantly regulated by ADR-
1 (Figure 1B). Because ADR-1 primarily promotes editing within
these target mRNAs, most of the sites exhibit decreased editing
in the absence of adr-1, with the exception of nt 631 of lam-2,
which has increased editing in adr-1() worms (Figure 1A). The
ADR-1 ds1+2 mutant failed to significantly restore editing to 11
of these 15 sites, including nt 631 of lam-2 (Figure 3D). Thus,
ADR-1 binding to target mRNAs is required both for its ability
to promote and inhibit editing of known edited mRNAs in vivo.
Binding of dsRNA by ADR-1 Regulates Editing across
the Transcriptome
Our data indicate that ADR-1 binding to target mRNAs alters
editing of specific adenosines in vivo. To understand the impact
of ADR-1 across the transcriptome, we conducted strand-spe-
cific RNA sequencing (RNA-seq) of RNA from wild-type (CEN2),
adr-1(), adr-2(), FLAG-ADR-1, and FLAG-ADR-1 ds1+2
mutant adult worms and compared the nucleotide changes
among the strains and the published C. elegans genomic
sequence (WS220,ce10) (Figure 4A). To distinguish true RNA
editing events from SNPs, we removed annotated SNPs using
Illumina’s iGenomes collection. Unannotated single-nucleotide
variants (SNVs) were further addressed by performing RNA-
seq on RNA from adr-1();adr-2() worms and identifying all
SNVs between the adr-1();adr-2() RNA (which lacks all A-to-
I editing) and the C. elegans genome. These 118,651 SNVs
were subtracted from all other RNA-seq data sets. A Bayesian
‘‘inverse probability model’’ was then adapted (Li et al., 2008)
to identify high-confidence A-to-I editing sites from the RNA-
seq data, where a confidence value based on the number
of reads is associated with each predicted site. Empirically, we602 Cell Reports 6, 599–607, February 27, 2014 ª2014 The Authorsfound that a confidence threshold of 0.995 produced the largest
number of predicted sites in all strains: 59 sites in N2, 141 sites in
adr-1(), 71 sites in FLAG-ADR-1, 102 sites in FLAG-ADR-1
ds1+2 mutant, while identifying the lowest number of edits in
the adr-2() strain (six sites) that we presumed represented
false positives (Table S1).
Of the 270 unique high-confidence editing sites that were
identified, but not present in adr-2()worms (Table S1), 250 sites
are editing events that occur within 48 different transcripts; the
remaining 20 high-confidence sites were located within the
previously identified ADAR targets C35E7.6, lam-2, and rncs-1
(Morse et al., 2002; Morse and Bass, 1999). The majority (96%)
of these candidate editing events occur within noncoding
regions of the genome (Figure 4B). Strikingly, the vast majority
of editing events occurred in 30 UTRs, consistent with the
hypothesis that A-to-I editing controls gene expression by
altering regulatory motifs in these regions. Interestingly, regions
of the genome that encode for transposons were the second
most highly identified (18%) category of editing events. In addi-
tion, we did identify 11 potential editing sites in coding regions of
eight different mRNAs. As editing events in the coding region of
C. elegans mRNAs had not previously been identified, this
suggests that, similar to mammalian and Drosophila ADARs,
C. elegans ADARsmay also perform site selective editing in vivo.
Although ADARs target dsRNA of any sequence, the extent of
editing at a particular site depends on the neighboring nucleo-
tides (Wahlstedt and Ohman, 2011). Using the Two Sample
Logo software (Vacic et al., 2006), the 270 candidate editing
sites had an overrepresentation of A both immediately 50 and
30 to the edited adenosine, whereas both G and C are underrep-
resented at the positions 50 to the edited adenosine, and C is
underrepresented 30 to the edited adenosine (Figure 4C). Both
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Figure 3. Mutation of the KKxxK Motif within the dsRBDs of ADR-1 Abolishes dsRNA Binding and Editing Regulation
(A) Schematic of ADR-1 protein with dsRBDs (gray ovals) and deaminase domain (patterned rectangle). Lysine (K) residues mutated are indicated above each
dsRBD.
(B) FLAG immunoblotting of lysates and IPs of the indicated strains.
(C) Ratio of the cDNA present in the IP samples divided by the input cDNA levels for the indicated strains were divided by the IP:input ratio of the adr-1()worms.
Error bars represent SEM for three biological replicates.
(D) Calculated percent editing in the indicated strains for the endogenous mRNAs of C35E7.6, lam-2, and pop-1. Error bars represent SEM of three biological
replicates. Significant changes (p% 0.05) in editing levels between FLAG-ADR-1 and FLAG-ADR-1 ds1+2 mutant are marked with an asterisk.in vitro biochemical studies and transcriptome-wide RNA-seq
data indicate that human ADARs have a similar 50 preference.
However human ADARs tend to favor a G at the 30 position to
the edited adenosine (Lehmann and Bass, 2000; Riedmann
et al., 2008). It is important to note that because of overlapping
specificities of mammalian ADARs, human transcriptome-wide
data sets apply to editing by both human ADAR1 and ADAR2.
However, becauseC. elegansADR-2 is responsible for deamina-
tion of all of the sites, our data provide in vivo nucleotide
preferences of a single ADAR acting primarily at noncoding
regions.
To validate the potential editing sites, Sanger sequencing
editing assays were performed for nine edited transcripts (Fig-
ure S2A). Importantly, 50 of the 53 predicted sites were verified
by Sanger sequencing, suggesting the false discovery rate of
the pipeline is approximately 5.7%. In addition to the 50 editing
sites identified from the RNA-seq analysis, Sanger sequencing
of these nine transcripts revealed 179 additional editing sites
(Table S2), indicating that our probabilistic model is capable of
identifying highly edited transcripts.
To determine if ADR-1 affected editing across the transcrip-
tome, the editing efficiency of the 270 high-confidence editing
sites was quantified using a Bayesianmodel. To ensure accurate
quantification, we processed all the RNA-seq reads through the
bioinformatics pipeline described above (Figure 4A), with one
exception: read filter 5d was relaxed from requiring an edit site
to be 25 nt from each end down to a less-stringent 5 nt andCrequired a minimum of five reads for a site in a given strain.
With these criteria, we were able to quantify editing of over 100
sites for each of the four strains, with any two strains having an
overlap of between 72 and 105 editing sites (Figures S2B–S2E).
Pairwise comparison of the editing sites identified from the four
RNA-seq data sets indicated that editing efficiency is most
consistent between the wild-type and FLAG-ADR-1 strains (Fig-
ures 4D and S2F–S2H). This is consistent with the Sanger
sequencing data of known editing sites and provides further
evidence that the FLAG-ADR-1 transgene is capable of restoring
editing to the adr-1() strain at most sites. Because over two-
thirds of the wild-type and FLAG-ADR-1 sites fell within one SD
(12%) of the regression line on the scatterplot, we used this
threshold to categorize our newly identified sites into ADR-1
and non-ADR-1 regulated (Table S3). As multiple RNA-seq
studies have shown that determination of editing levels increases
with read coverage (Bahn et al., 2012; Lee et al., 2013), it is impor-
tant to note that similar results (>80% overlap) were obtained
when we utilized read density to estimate the error of editing at
each site (Table S3), suggesting that the editing percent thresh-
olds for ADR-1-regulated and nonregulated sites are accurate.
Comparison of editing levels at the 81 sites common between
wild-type and adr-1() RNA-seq data sets revealed that over
half (56%) of the edited adenosines have altered editing levels
in the absence of adr-1 (Table S3). Interestingly, 44 of these 45
sites are located within the 30 UTRs of 13 edited transcripts that
we identified. These data are consistent with our quantitativeell Reports 6, 599–607, February 27, 2014 ª2014 The Authors 603
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Figure 4. Impact of dsRNA Binding by ADR-1 on the Editing Transcriptome
(A) Bioinformatics strategy depicting the major steps for processing RNA-seq data into A-to-I sites for each strain.
(B) Distribution of identified RNA editing sites within annotated transcriptome regions.
(C) Nucleotide preferences for the 270 candidate editing sites were calculated compared to a randomized control. Enriched and depleted nucleotides are shown
above and below the axis, respectively. The level of conservation is represented by letter height. Logos were generated using a Student’s t test with p < 0.005 and
no Bonferroni correction.
(D) Scatterplots of percent editing of quantified sites that overlap in thewild-type (CEN2) and FLAG-ADR-1 data sets. The r2 fit to the y = x line (black diagonal). The
margin (dotted line) between no-change and differentially edited sites equals 12 units of change in the edit percent (one SD).
(E) Editing levels for 13 sites from the RNA-seq data where editing levels between adr-1() and FLAG-ADR-1 and between FLAG-ADR-1 and FLAG-ADR-1 ds1+2
mutant were greater than 12% (Table S3). Adenosines that had no observed editing are marked with a zero above the x axis.
(F and G) Immunoblotting analysis of FLAG IPs from the indicated strains. IPs were performed as previously stated except worms were not subjected to UV
crosslinking and only light salt washes were employed.Sanger sequencing analysis of the 30 UTRs of known ADAR tar-
gets (Figure 1A). In addition, at 38 of these ADR-1-regulated sites
we were able to quantify editing levels for both the FLAG ADR-1
and FLAG-ADR-1 ds1+2 mutant RNA-seq data sets. Editing
levels at 13 sites located within the 30 UTRs of eight newly iden-
tified ADAR target mRNAs were dependent upon dsRNA binding
by ADR-1 (Figure 4E). Together these transcriptome-wide
studies indicate that ADR-1 regulates editing of specific adeno-
sines within the 30 UTRs of the majority of C. elegans edited
mRNAs and dsRNA binding is required for this function.604 Cell Reports 6, 599–607, February 27, 2014 ª2014 The AuthorsADR-1 and ADR-2 Co-occupy Transcripts In Vivo
At present, it is unclear how ADR-1 binding to mRNAs affects
editing by ADR-2. It is possible that ADR-1 and ADR-2 heterodi-
merize in the cell to edit certain transcripts, whereas others are
edited by ADR-2 alone. Alternatively, it is possible that ADR-1
and ADR-2 interact on the same transcripts but regulate editing
in an adenosine-specific manner. To gain insight into these pos-
sibilities, we examined the wild-type and FLAG-ADR-1 RNA-seq
data sets to determine whether editing at ADR-1-regulated
adenosines occurred on the same reads as edited adenosines
that are not affected by loss of adr-1. For most of the transcripts
edited in the 30 UTR (9/12), editing was observed at both adeno-
sines affected by adr-1 and nonregulated sites, within the same
75 nt read (Table S3).
To provide further evidence that ADR-1 and ADR-2 associate
on common targets in vivo, we immunoprecipitated FLAG-ADR-
1 and tested for the presence of ADR-2 with an ADR-2-specific
antibody (Figure 4F). ADR-2 was present in IPs from FLAG-
ADR-1 worms, but not FLAG-ADR-1 ds1+2 mutant or adr-1()
worms (Figure 4G). Consistent with an RNA-dependent interac-
tion of ADR-1 and ADR-2, IPs of wild-type ADR-1 treated with
RNase also resulted in reduced ADR-2 coimmunoprecipitation
(Figures S2J and S2K). Together, these data suggest that
ADR-1 and ADR-2 interact on transcripts in vivo but are not likely
to heterodimerize independent of target mRNAs.
DISCUSSION
In this study, we have demonstrated that C. elegans ADR-1 uti-
lizes its dsRNA binding function to regulate A-to-I editing levels
in vivo. Using a high-throughput RNA sequencing approach
coupled to probabilistic modeling, we were able to expand the
number of known ADAR target mRNAs 5-fold as well as provide
transcriptome-wide evidence that ADR-1 is a catalytically inac-
tive member of the ADAR family. Furthermore, using both our
extensive Sanger sequencing analysis of ADAR targets and
quantification of transcriptome-wide RNA-seq data, we demon-
strate that ADR-1 regulates editing efficiency of specific adeno-
sines within most ADAR target 30 UTRs.
We propose that ADR-1 regulates editing by binding to target
mRNAs and altering accessibility of ADR-2 for specific adeno-
sines. Multiple recent studies support the idea that the RNA
binding protein (RBP) landscape of ADAR target mRNAs affects
editing levels (Bhogal et al., 2011; Garncarz et al., 2013; Tariq
et al., 2013). However, in most of these studies, RNA binding
by the regulators was not shown to be required for A-to-I regula-
tory activity, and these regulators were all single-stranded RBPs
that altered editing of specific coding editing events. In contrast,
we demonstrate that ADR-1 binds to several target mRNAs via
its dsRBDs, and that this binding is required for regulation of
editing. This dsRNA binding activity would allow ADR-1 to
interact with nearly all the same targets as ADR-2, thus allowing
it to serve amore global role in regulating editing within long dou-
ble-stranded regions. Because dsRBDs are the second most
abundant RNA recognition motif (Stefl et al., 2010), it is unlikely
that this regulatory role is limited to C. elegans ADR-1. Consis-
tent with this, 20% of our newly discovered edited transcripts
overlap with recently identified targets of another dsRNA binding
protein (dsRBP), C. elegans Staufen (LeGendre et al., 2013)
(Table S1).
Our Sanger sequencing and transcriptome-wide analyses
suggest that the regulatory role of ADR-1 is specific to certain
adenosines (Figure 1A; Table S3). Although dsRBPs are gener-
ally presumed to lack sequence specificity (Tian et al., 2004),
recent structural data suggest ADARs recognize specific nucle-
otides within dsRNA (Stefl et al., 2010). Our RIP assay indicates
that ADR-1 binds to lam-2 and pop-1 mRNAs to a similar extent
in the presence and absence of adr-2 (Figure 2D). Thus, at leastCfor certain edited mRNAs, ADR-1 does not compete with ADR-2
for binding sites in vivo. Consistent with this, the majority of the
ADR-1-regulated sites identified in both the RNA-seq data sets
and Sanger analysis have enhanced editing in the presence of
adr-1 (Figure 1A; Table S3), suggesting that ADR-1 functions
primarily to promote ADR-2 editing, not compete with ADR-2
for target adenosines. Given that editing is not required for
ADR-1 to bind these mRNAs, we postulate that, in vivo, ADR-1
first binds to target mRNAs and then either alters binding of
ADR-2 to specific regions and/or regulates the catalytic activity
of ADR-2. Interestingly, it was recently demonstrated that
human ADAR1 binding to mRNAs creates binding sites for
another RBP, HuR, which results in increased RNA stability of
HuR-ADAR1 bound transcripts (Wang et al., 2013). Similar to
human ADAR1-HuR, we detected an in vivo interaction between
wild-type ADR-2 and ADR-1, but not the ADR-1 ds1+2 mutant,
which is consistent with ADR-1 and ADR-2 interacting on target
mRNA. Interestingly, it has previously been suggested that hu-
man ADAR homodimerization on dsRNA is required for efficient
editing in vitro (Jaikaran et al., 2002). Although our evidence
indicates that ADR-1 utilizes dsRNA binding to regulate editing,
it is possible that this regulatory function is due to effects of
ADR-1 on expression of other RBPs, which, in turn, alter ADR-
2 accessibility to target mRNAs. Future work aimed at both
identifying ADR-1 and ADR-2 binding sites on mRNAs in vivo
and determining the impact of ADR-1 on ADR-2 editing activity
in vitro will be needed to determine if there is a correlation
between binding site specificity and regulation of specific sites.
In summary, our results indicate that ADR-1 utilizes dsRNA
binding to regulate A-to-I editing across theC. elegans transcrip-
tome. These studies not only suggest a potential biological
function for the catalytically inactive ADARs present in humans,
but also unveil a potential mechanism for other dsRBPs to
regulate RNA editing levels.
EXPERIMENTAL PROCEDURES
Maintenance of Worm Strains and Transgenics
Worm strains were maintained by growth on NGM plates seeded with
Escherichia coli OP50. A detailed description of the transgenic strains is
given in the Supplemental Experimental Procedures.
RNA Isolation and Editing Assays
Total RNA was isolated using Trizol (Invitrogen). RNA was further treated
with Turbo DNase (Ambion) and then isolated using the RNA Easy Extraction
kit (QIAGEN). Editing assays were performed using Thermoscript (Invitrogen)
for reverse transcription and PFX Platinum DNA Polymerase (Invitrogen) for
PCR amplification with gene-specific primers (Table S4). PCR products were
gel purified and subjected to Sanger sequencing. For all editing assays, nega-
tive controls were conducted without Thermoscript RT to ensure that all DNA
subjected to sequencing resulted from cDNA amplification.
Strand-Specific RNA Sequencing
Strand-specific mRNA sequencing libraries were prepared as described
previously (Parkhomchuk et al., 2009). Libraries were normalized to 2 nM
and sequenced for SE76 cycles on either HiSeq2000 [adr-1();adr-2()]or
Illumina GAII (all other strains).
Bioinformatics Pipeline
To achieve accurate identification of editing sites, we combined filters from ex-
isting pipelines (Chen, 2013; Lee et al., 2013; Levanon et al., 2004; Ramaswamiell Reports 6, 599–607, February 27, 2014 ª2014 The Authors 605
et al., 2012) in a strand-specific manner. Accurate quantification was per-
formed by extending the existing Bayesian method for genomic variant calling
used in the 1000 Genomes project (Li et al., 2008) with a custom-designed
prior on the editing percent (Figure S2I). In addition to leveraging established
considerations with regards to read sequencing and alignment errors (Klein-
man and Majewski, 2012; Lin et al., 2012; Pickrell et al., 2012), our approach
benefits greatly from using the adr-1();adr-2() strain as a powerful filter for
unannotated variants. Detailed steps of the pipeline and Bayesian method
for variant calling are described in the Supplemental Experimental Procedures.
RNA Immunoprecipitation Assay
After washing with IP buffer (50 mM HEPES [pH 7.4]; 70 mM K-Acetate, 5 mM
Mg-Acetate, 0.05% NP-40, and 10% glycerol), worms were subjected to
3J/cm2 of UV radiation using the Spectrolinker (Spectronics) and stored at
80C. To obtain cell lysates, frozen worms were ground with a mortar
and pestle on dry ice. After thawing, the lysate was centrifuged and protein
concentration was measured with Bradford reagent (Sigma-Aldrich). Five mi-
crograms of extract was added to anti-FLAG magnetic beads (Sigma-Aldrich)
that were washed with wash buffer (WB: 0.5 M NaCl, 160 mM Tris-HCl
[pH 7.5]). After incubation for 1 hr at 4C, the beads were washed with ice-
cold WB, resuspended in low-salt WB (0.11M NaCl), 1 ml RNasin (Promega),
and 0.5 ml of 20 mg/ml proteinase K (Sigma-Aldrich) and incubated at 42C
for 15 min to degrade protein and release bound RNA. Protein samples were
subjected to SDS-PAGE and western blotting with a FLAG antibody (Sigma-
Aldrich). RNA samples were isolated as described above. Following DNase
treatment, quantitative real-time PCR for known editing targets was performed
as previously described (Hundley et al., 2008).
Flow Cytometry
Flow cytometry was conducted at the IUB Flow Cytometry Facility by a dedi-
cated technician using the COPAS Select (Union Biometrica) large particle
sorter. Parameters were adjusted to select adult worms and expressing GFP
for transgenic lines.
ACCESSION NUMBERS
Both the raw RNA sequencing data and the processed expression matrix
are publicly available on NCBI Gene Expression Omnibus under accession
number GSE51556.
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